Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension
Clinical trial NCT06643156 · COMPLETED
Trial details
- NCT number
- NCT06643156
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-27
- Primary completion
- 2025-01-18
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.